Oral Crohn's disease: Is it a separable disease from orofacial granulomatosis? A review

Journal of Crohn's and Colitis

Volumn 6, Issue 2, 2012, Pages 135-142

  Zbar, Andrew P ^a   Ben Horin, Shomron ^a   Beer Gabel, Marc ^a   Eliakim, Rami ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Crohn's disease; ; Oral Crohn's disease; ; Orofacial granulomatosis

Indexed keywords

BECLOMETASONE; IMMUNOGLOBULIN A; MESALAZINE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ANEMIA; APHTHOUS STOMATITIS; ARTHRITIS; BEHCET DISEASE; BLOATING; BRONCHOSCOPY; BUCCAL MUCOSA SWELLING; CANDIDIASIS; CAT SCRATCH DISEASE; CD4 LYMPHOCYTE COUNT; CELIAC DISEASE; CHEILITIS; COLONOSCOPY; COUGHING; COXSACKIE VIRUS INFECTION; CROHN DISEASE; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DEEP MYCOTIC ULCER; DERMATITIS; DERMATITIS HERPETIFORMIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DUODENOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA NODOSUM; FACE SWELLING; FEVER; FOREIGN BODY GRANULOMA; FRANK ULCER; GASTROSCOPY; GENITAL ULCER; GLOSSITIS; GRANULOMA; HELPER CELL; HEMOPTYSIS; HERPES SIMPLEX; HISTOPATHOLOGY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LEUKOCYTOSIS; LICHEN PLANUS; LIP FISSURE; LIP SWELLING; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHANGITIS; MACROPHAGE; MELKERSSON ROSENTHAL SYNDROME; MOUTH CANCER; MOUTH DISEASE; MOUTH ULCER; MUCOSAL TAG; NUTRITIONAL DEFICIENCY; ORAL BIOPSY; ORAL CROHN DISEASE; ORAL MUCOSAL DISEASE; OROFACIAL GRANULOMATOSIS; PALATE ULCER; PAPULE; PARACOCCIDIOIDES; PEMPHIGUS; PERIODONTAL DISEASE; PRIORITY JOURNAL; RASH; RECTUM HEMORRHAGE; REVIEW; SACCHAROMYCES CEREVISIAE; SARCOIDOSIS; STOMATITIS; SWELLING; SYPHILIS; T CELL LYMPHOMA; THORAX RADIOGRAPHY; TONGUE DISEASE; TONGUE FISSURE; TUBERCULOSIS; UVEITIS; VASCULITIS; VIRUS LOAD; WEGENER GRANULOMATOSIS; WEIGHT REDUCTION;

CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; GRANULOMATOSIS, OROFACIAL; HUMANS; INTESTINES; ORAL ULCER;

EID: 84856754326     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.07.001     Document Type: Review

References (82)

1. Scully C., Eveson J.W. Oral granulomatosis (Leading article). Lancet 1991, 338:20-21.
2. Eveson J.W. Granulomatous disorders of the oral mucosa. Semin Diagn Pathol May 1996, 13(2):118-127.
3. Alawi F. Granulomatous diseases of the oral tissues: differential diagnosis and update. Dent Clin North Am Jan 2005, 49(1):203-221.
4. Wiesenfield D., Ferguson M.M., Mitchell D.N., MacDonald D.G., Scully C., Cochran K., Russell R.I. Orofacial granulomatosis-a clinical and pathological analysis. Q J Med Jan 1985, 54(213):101-113.
5. Talbot T., Jewell L., Schloss E., Yakimets W., Thomson A.B. Cheilitis antedating Crohn's disease: case report and literature update of oral lesions. J Clin Gastroenterol Aug 1984, 6(4):349-354.
6. Coenen C., Börsch G., Müller K.M., Fabry H. Oral inflammatory changes as an initial manifestation of Crohn's disease antedating abdominal diagnosis. Report of a case. Dis Colon Rectum Jul 1988, 31(7):548-552.
7. Lisciandrano D., Ranzi T., Carassi A., Sardella A., Campanini M.C., Velio P., Bianchi P.A. Prevalence of oral lesions in inflammatory bowel disease. Am J Gastroenterol Jan 1996, 91(1):7-10.
8. Field E.A., Allan R.B. Oral ulceration-aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic. Aliment Pharmacol Ther Nov 2001, 18:949-962.
9. Jahanbani J., Sandvik L., Lyberg T., Ahlfors E. Evaluation of oral mucosal lesions in 598 referred Iranian patients. Open Dent J Mar 2009, 3:42-47.
10. Reamy B.V., Derby R., Bunt C.W. Common tongue conditions in primary care. Am Fam Physician Mar 2010, 81(5):627-634.
11. Halme L., Meurman J.H., Laine P., von Smitten K., Syrjänen S., Lindqvist C., Strand-Pettinen I. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol Aug 1993, 76(2):175-181.
12. Rowland M., Fleming P., Bourke B. Looking in the mouth for Crohn's disease. Inflamm Bowel Dis Feb 2010, 16(2):332-337.
13. Ojha J., Cohen D.M., Islam N.M., Stewart C.M., Katz J., Bhattacharya I. Gingival involvement in Crohn's disease. J Am Dent Assoc Dec 2007, 138(12):1574-1581.
14. Baniţǎ M., Pisoschi C., Stǎnciulescu C., Scrieciu M., Tuculinǎ M., Mercuţ V., Cǎruntu I.D. Idiopathic gingival hypertrophy-a morphological study and a review of literature. Rev Med Chir Soc Med Nat Iasi Oct-Dec 2008, 112(4):1076-1083.
15. Gagoh O.K., Qureshi R.M., Hendrickse M.T. Recurrent buccal space abscesses: a complication of Crohn's disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Jul 1999, 88(1):33-36.
16. Sundh B., Emilson C.G. Salivary and microbial conditions and dental health in patients with Crohn's disease: a 3year study. Oral Surg Oral Med Oral Pathol Mar 1989, 67(3):286-290.
17. Mdinaridze G.N., Rumiantsev V.G., Maksimovskiǐ IuM, Iurkov Miu State of the mouth cavity in patients with inflammatory intestinal diseases. Eksp Klin Gastroenterol 2006, 4:17-21. 114.
18. Plauth M., Jenss H., Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol Feb 1991, 13(1):29-37.
19. Femiano F., Lanza A., Buonaiuto C., Perillo L., Dell'Ermo A., Cirillo N. Pyostomatitis vegetans: a review of the literature. Med Oral Patol Oral Cir Bucal Mar 2009, 14(3):E114-E117.
20. Pazheri F., Alkhouri N., Radhakrishnan K. Pyostomatitis vegetans as an oral manifestation of Crohn's disease in a pediatric patient. Inflamm Bowel Dis Dec 2010, 16(12):2007.
21. Said S., Golitz L. Vesiculobullous eruptions of the oral cavity. Otolaryngol Clin North Am Feb 2011, 44(1):133-160.
22. Diamond T., Patterson P.G., Emerson T.G. Oral Crohn's disease: the distinction from the Melkersson-Rosenthal syndrome. Ulster Med J Oct 1990, 59(2):223-224. 186.
23. Ratzinger G., Sepp N., Vogetseder W., Tilg H. Cheilitis granulomatosa and Melkersson-Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patients. J Eur Acad Dermatol Venereol Sep 2007, 21(8):1065-1070.
24. Mignogna M.D., Fedele S., Lo Russo L., Lo Muzio L. The multiform and variable patterns of onset of orofacial granulomatosis. J Oral Pathol Med Apr 2003, 32(4):200-205.
25. Langevitz P., Engelberg J.S., Tsur H., Cabili S. Melkersson-Rosenthal syndrome: an oligosymptomatic form. South Med J Sep 1986, 79(9):1159-1160.
26. Sciubba J.J., Said-Al-Naief N. Orofacial granulomatosis: presentation, pathology and management of 13 cases. J Oral Pathol Med Nov 2003, 32(10):576-585.
27. Leão J.C., Hodgson T., Scully C., Porter S. Review article: orofacial granulomatosis. Aliment Pharmacol Ther Nov 15 2004, 20(10):1019-1027.
28. Stewart C.M., Watson R.E. Experimental oral foreign body reactions. Commonly employed dental materials. Oral Surg Oral Med Oral Pathol Jun 1990, 69(6):713-719.
29. Mignogna M.D., Muzio L.L., Favia G., Ruoppo E., Sammartino G., Zarrelli C., Bucci E. Oral tuberculosis: a clinical evaluation of 42 cases. Oral Dis Jan 2000, 6(1):25-30.
30. Ng K.H., Siar C.H. Review of oral histoplasmosis in Malaysians. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Mar 1996, 81(3):303-307.
31. Almeida O.P., Jacks J., Scully C. Paracoccidioidomycosis of the mouth: an emerging deep mycosis. Crit Rev Oral Biol Med 2003, 14(5):377-383.
32. Blinder D., Yahatom R., Taicher S. Oral manifestations of sarcoidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Apr 1997, 83(4):458-461.
33. Tarpley T.M., Anderson L., Lightbody P., Sheagren J.N. Minor salivary gland involvement in sarcoidosis. Report of 3 cases with positive lip biopsies. Oral Surg Oral Med Oral Pathol May 1972, 33(5):755-762.
34. Miyoshi S., Hamada H., Kadowaki T., Hamaguchi N., Ito R., Irifume K., Higaki J. Comparative evaluation of serum markers in pulmonary sarcoidosis. Chest Jun 2010, 137(6):1391-1397.
35. Matsumoto T., Nakamura S., Jin-no Y., Sawa Y., Hara J., Oshitani N., Arakawa T., Otani H., Nagura H. Role of granuloma in the immunopathogenesis of Crohn's disease. Digestion 2001, 63(Suppl. 1):43-47.
36. Harty S., Fleming P., Rowland M., Crushell E., McDermott M., Drumm B., Bourke B. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol Sep 2005, 3(9):886-891.
37. Freysdottir J., Zhang S., Tilakaratne W., Fortune F. Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis Apr 2007, 13(4):439-445.
38. Pallone F., Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut Dec 1998, 43(6):735-736.
39. Cuthbert A., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., Mascheretti S., Sanderson J., Forbes A., Mansfield J., Schreiber S., Lewis C.M., Mathew C.G. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology Apr 2002, 122(4):867-874.
40. Henckaerts L., Vermeire S. NOD2/CARD15 disease associations other than Crohn's disease. Inflamm Bowel Dis 2007, 13:235-241.
41. Savage N.W., Barnard K., Shirlaw P.J., Rahman D., Mistry M., Escudier M.P., Sanderson J.D., Challacombe S.J. Serum and salivary IgA antibody responses to Saccharomyces cerivisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease. Clin Exp Immunol Mar 2004, 135(3):483-489.
42. Lim S.H., Stephens P., Cao Q.-X., Coleman S., Thomas D.W. Molecular analysis of T cell receptor beta variability in a patient with orofacial granulomatosis. Gut May 1997, 40(5):683-686.
43. Yantiss R.K., Odze R.D. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol Apr 2007, 102(4):890-904.
44. Sweatman M.C., Tasker R., Warner J.O., Ferguson M.M., Mitchell D.M. Orofacial granulomatosis. Response to elemental diet and provocation by food additives. Clin Allergy 1986, 16:331-338.
45. Wray D., Rees S.R., Gibson J., Forsyth A. The role of allergy in oral mucosal diseases. QJM Aug 2000, 93(8):507-511.
46. Fitzpatrick L., Healy C.M., McCartan B.E., Flint S.R., McCreary C.E., Rogers S. Patch testing for food-associated allergies in orofacial granulomatosis. J Oral Path Med Jan 2011, 40(1):10-13.
47. Scully C., Cochran K.M., Russel R., Ferguson M.M., Ghouri M.A., Lee F.D., MacDonald D.G., McIntyre P.B. Crohn's disease of the mouth: an indicator of intestinal involvement. Gut Mar 1982, 23(3):198-201.
48. Dupuy A., Cosnes J., Revuz J., Delchier J.C., Gendre J.P., Cosnes A. Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol Apr 1999, 135(4):439-442.
49. Hussey S., Fleming P., Rowland M., Harty S., Chan L., Broderick A., Drumm B., Bourke B. Disease outcome for children who present with oral manifestations of Crohn's Disease. Eur Arch Paediatr Dent 2011 Jum, 12(3):167-169.
50. Wolters F.L., Russel M.G., Sijbrandij J., Schouten L.J., Odes S., Riis L., Munkholm P., Bodini P., O'Morain C., Mouzas I.A., Tsianos E., Vermeire S., Monteiro E., Limonard C., Vatn M., Fornaciari G., Pereira S., Moum B., Stockbrügger R.W. European Collaborative study group on Inflammatory Bowel Disease (EC-IBD). Crohn's disease: increased mortality 10years after diagnosis in a Europe-wide population based cohort. Gut Apr 2006, 55(4):510-518.
51. Gomez R.S., Ozen I.Y., Peters K.P., Simon M., Hornstein O.P. Crohn disease-initial manifestation in the oral and anogenital area. Hautarzt Jul 1989, 40(7):451-455.
52. Monsén U., Sorstad J., Hellers G., Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol Jun 1990, 85(6):711-716.
53. Lakatos L., Pendur T., David G., Balogh Z., Kuronya P., Tollas A., Lakatos P.L. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol Oct 2003, 9:2300-2307.
54. Greenstein A.J., Janowitz H.D., Sachar D.B. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 792 patients. Medicine Sep 1976, 55(5):401-412.
55. Bernstein C.N., Blanchard J.F., Rawsthorne P., Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol Apr 2001, 96(4):1116-1122.
56. Vavricka S.R., Brun L., Ballabeni P., Pittet V., Prinz Vavricka B.M., Zeitz J., Rogler G., Schoepfer A.M. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol Jan 2011, 106(1):110-119.
57. Das K.M. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci Jan 1999, 44(1):1-3.
58. Dotson J.L., Hyams J.S., Markowitz J., LeLeiko N.S., Mack D.R., Evans J.S., Pfefferkorn M.D., Griffiths A.M., Otley A.R., Bousvaros A., Kugathasan S., Rosh J.R., Keljo D., Carvalho R.S., Tomer G., Mamula P., Kay M.H., Kerzner B., Oliva-Hemker M., Langton C.R., Crandall W. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to diseases type and severity. J Pediatr Gastroenterol Nutr Aug 2010, 51(2):140-145.
59. Jiang L., Xia B., Li J., Ye M., Yan W., Deng C., Ding Y., Luo H., Hou W., Zhao Q., Liu N., Ren H., Hou X., Xu H. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis Mar 2006, 12(3):212-217.
60. Yüksel I., Başar Ö., Ataseven H., Ertuǧrul I., Arhan M., Ibiş M., Daǧli Ü., Tunç Demirel B., Ülker A., Seçilmiş S., Şaşmaz N. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis Apr 2009, 15(4):546-550.
61. Greenberg M.S., Pinto A. Etiology and management of recurrent aphthous stomatitis. Curr Infect Dis Rep Jun 2003, 5(3):194-198.
62. Chattopadhyay A., Chatterjee S. Risk indicators for recurrent aphthous ulcers among adults in the U.S. Community Dent Oral Epidemiol Apr 2007, 35(2):152-159.
63. Field E.A., Tyldesley W.R. Oral Crohn's disease revisited-a 10year review. Br J Oral Maxillofac Surg Apr 1989, 27(2):114-123.
64. Challacombe S.J. Oro-facial granulomatosis and oral Crohn's disease: are they specific diseases and do they predict systemic Crohn's disease?. Oral Dis Sep 1997, 3(3):127-129.
65. Tilakaratne W.M., Freysdottir J., Fortune F. Orofacial granulomatosis: review of aetiology and pathogenesis. J Oral Pathol Med Apr 2008, 37(4):191-195.
66. Al Johani K.A., Moles D.R., Hodgson T.A., Porter S.R., Fedele S. Orofacial granulomatosis: clinical features and long-term outcome of therapy. J Am Acad Dermatol 2010 Apr, 62(4):611-620.
67. Endo H., Rees T.D. Cinnamon products as a possible etiologic factor in orofacial granulomatosis. Med Oral Patol Oral Cir Bucal 2007 Oct 1, 12(6):E440-E444.
68. White A., Nunes C., Escudier M., Lomer M.C., Barnard K., Shirlaw P., Challacombe S.J., Sanderson J.D. Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet. Inflamm Bowel Dis Jun 2006, 12(6):508-514.
69. Otake K., Uchida K., Inoue M., Ohkita Y., Araki T., Miki C., Kusunoki M. Successful treatment with topical 5-Aminosalicylic acid ointment and spray of refractory oral and pharyngeal ulcerations in a child with Crohn's disease. J Pediatr Gastroenterol Nutr Mar 2007, 44(3):378-381.
70. Mignogna M.D., Fedele S., Lo Russo S., Adamo D., Satriano R.A. Effectiveness of small-volume, intralesional, delayed-release triamcinolone injections in orofacial granulomatosis: a pilot study. J Am Acad Dermatol Aug 2004, 51(2):265-268.
71. Casson D.H., Eltumi M., Tomlin S., Walker-Smith J.A., Murch S.H. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut Sep 2000, 47(3):436-440.
72. Hodgson T., Hegarty A., Porter S. Topical tacrolimus and Crohn's disease. J Pediatr Gastroenterol Nutr Nov 2001, 33(5):633.
73. Tyldesley W.R. Oral Crohn's disease and related conditions. Br J Oral Surg Jul 1979, 17(1):1-9.
74. Mahadevan U., Sandborn W.J. Infliximab for the treatment of orofacial Crohn's disease. Inflamm Bowel Dis Feb 2001, 7(1):38-42.
75. Elliott E., Campbell H., Escudier M., Poate T., Nunes C., Lomer M., Mentzer A., Patel P., Shirlaw P., Brostoff J., Challacombe S., Sanderson J. Experience with anti-TNF-α therapy for orofacial granulomatosis. J Oral Pathol Med Jan 2011, 40(1):14-19.
76. Hegarty A., Hodgson T., Porter S. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod May 2003, 95(5):576-585.
77. Bens G., Laharie D., Beylot-Barry M., Vergier B., Noblesse I., Beylot C., Amouretti M. Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn's disease. Br J Dermatol Jul 2003, 149(1):181-184.
78. Van der Waal R.I., Schulten E.A., van der Meij E.H., van der Scheur M.R., Starink T.M., van der Waal I. Cheilitis granulomatosa: overview of 13 with long-term follow-up-results of management. Int J Dermatol Apr 2002, 41(4):225-229.
79. Shanahan F., Bernstein C.N. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol Jul 2009, 25(4):301-305.
80. Messadi D., Younai F. Aphthous ulcers. Dermatol Ther May-Jun 2010, 23(3):281-290.
81. Sanderson J., Nunes C., Escudier M., Barnard K., Shirlaw P., Odell E., Chinayama C., Challacombe S. Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease?. Inflamm Bowel Dis 2005, 11:840-846.
82. Campbell H., Escudier M., Patel P., Nunes C., Elliott T.R., Barnard K., Shirlaw P., Poate T., Cook R., Milligan P., Brostoff J., Mentzer A., Lomer M.C., Challacombe S.J., Sanderson J.D. Distinguishing orofacial granulomatosis from Crohn's disease: two separate disease entities?. Inflamm Bowel Dis Jan 6 2011, [EPub ahead of print] DOI: 10.1002/ibd.21599.